Histamine-2 receptor antagonist use and incident dementia in an older cohort

Journal of the American Geriatrics Society

Volumn 59, Issue 2, 2011, Pages 251-257

  Gray, Shelly L ^a   Walker, Rod ^d   Dublin, Sascha ^b,d   Haneuse, Sebastien ^d   Crane, Paul K ^c   Breitner, John C S ^c,e   Bowen, James ^c   McCormick, Wayne ^c   Larson, Eric B ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d CENTER FOR HEALTH STUDIES   (United States)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; cohort study; dementia; histamine 2 receptor antagonist; pharmacoepidemiology

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST;

AGED; ALZHEIMER DISEASE; ARTICLE; COHORT ANALYSIS; DEMENTIA; DISEASE ASSOCIATION; DRUG EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHARMACY; PROSPECTIVE STUDY; RISK FACTOR; UNITED STATES;

AGED; AGED, 80 AND OVER; DEMENTIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; HISTAMINE H2 ANTAGONISTS; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; WASHINGTON;

EID: 79951597428     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.03275.x     Document Type: Article

References (27)

1. 2008 Top 200 generic drugs by total prescriptions. Drug Topics 2009;26: 4-6 [on-line]. Available at Accessed June 17, 2009.
2. Top 200 generics drugs by unit in 2007. Drug Topics. 2008 [on-line]. Available at Accessed June 17, 2009.
3. Esbenshade TA, Browman KE, Bitner RS, et al,. The histamine H3 receptor: An attractive target for the treatment of cognitive disorders. Br J Pharmacol 2008; 154: 1166-1181.
4. Haas HL, Sergeeva OA, Selbach O., Histamine in the nervous system. Physiol Rev 2008; 88: 1183-1241.
5. Hanlon JT, Landerman LR, Artz MB, et al,. Histamine2 receptor antagonist use and decline in cognitive function among community dwelling elderly. Pharmacoepidemiol Drug Saf 2004; 13: 781-787. (Pubitemid 39496900)
6. Zandi PP, Anthony JC, Hayden KM, et al,. Reduced incidence of AD with NSAID but not H2 receptor antagonists: The Cache County Study. Neurology 2002; 59: 880-886.
7. Breitner JC, Welsh KA, Helms MJ, et al,. Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging 1995; 16: 523-530.
8. Boustani M, Hall KS, Lane KA, et al,. The association between cognition and histamine-2 receptor antagonists in African Americans. J Am Geriatr Soc 2007; 55: 1248-1253. (Pubitemid 47106699)
9. Anthony JC, Breitner JC, Zandi PP, et al,. Reduced prevalence of AD in users of NSAIDs and H2 receptor antagonists: The Cache County Study. Neurology 2000; 54: 2066-2071. (Pubitemid 30397203)
10. Launer LJ, Jama JW, Ott A, et al,. Histamine H2 blocking drugs and the risk for Alzheimer's disease: The Rotterdam Study. Neurobiol Aging 1997; 18: 257-259. (Pubitemid 27355945)
11. Carlson MC, Tschanz JT, Norton MC, et al,. H2 histamine receptor blockade in the treatment of Alzheimer disease: A randomized, double-blind, placebo-controlled trial of nizatidine. Alzheimer Dis Assoc Disord 2002; 16: 24-30. (Pubitemid 34296619)
12. Gray SL, Lai KV, Larson EB., Drug-induced cognition disorders in the elderly: Incidence, prevention and management. Drug Saf 1999; 21: 101-122. (Pubitemid 29389171)
13. Montine TJ, Larson EB., Late-life dementias: Does this unyielding global challenge require a broader view? JAMA 2009; 302: 2593-2594.
14. Kukull WA, Higdon R, Bowen JD, et al,. Dementia and Alzheimer disease incidence: A prospective cohort study. Arch Neurol 2002; 59: 1737-1746. (Pubitemid 35340484)
15. Teng EL, Hasegawa K, Homma A, et al,. The Cognitive Abilities Screening Instrument (CASI): A practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 1994; 6: 45-58; discussion 62. (Pubitemid 24167129)
16. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th Ed. Washington, DC: American Psychiatric Association, 1994, pp. 886.
17. McKhann G, Drachman D, Folstein M, et al,. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34: 939-944. (Pubitemid 14076461)
18. Saunders KWDR, Stergachis A., Group Health Cooperative. In:, Strom BL, editor. Pharmacoepidemiology. Chichester: John Wiley & Sons, 2005, p 234.
19. Breitner JC, Haneuse SJ, Walker R, et al,. Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort. Neurology 2009; 72: 1899-1905.
20. Larson EB, Wang L, Bowen JD, et al,. Exercise is associated with reduced risk for incident dementia among persons 65 years of age and older. Ann Intern Med 2006; 144: 73-81. (Pubitemid 46768225)
21. Korn EL, Graubard BI, Midthune D., Time-to-event analysis of longitudinal follow-up of a survey: Choice of the time-scale. Am J Epidemiol 1997; 145: 72-80. (Pubitemid 27009060)
22. Chew ML, Mulsant BH, Pollock BG, et al,. Anticholinergic activity of 107 medications commonly used by older adults. J Am Geriatr Soc 2008; 56: 1333-1341.
23. Boudreau DM, Doescher MP, Saver BG, et al,. Reliability of Group Health Cooperative automated pharmacy data by drug benefit status. Pharmacoepidemiol Drug Saf 2005; 14: 877-884. (Pubitemid 43056114)
24. in t' Veld BA, Ruitenberg A, Hofman A, et al,. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001; 345: 1515-1521. (Pubitemid 33144916)
25. Heckbert SR, Kooperberg C, Safford MM, et al,. Comparison of self-report, hospital discharge codes, and adjudication of cardiovascular events in the Women's Health Initiative. Am J Epidemiol 2004; 160: 1152-1158. (Pubitemid 39628055)
26. Okura Y, Urban LH, Mahoney DW, et al,. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004; 57: 1096-1103. (Pubitemid 39446649)
27. Simpson CF, Boyd CM, Carlson MC, et al,. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: Factors that modify agreement. J Am Geriatr Soc 2004; 52: 123-127. (Pubitemid 38090401)